The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report deals with transdermal drug ...

CAMBRIDGE, MA--(Marketwire - Jan 3, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's ...

Proteins and peptides now constitute a major proportion of therapeutic modalities being pursued for the treatment of various diseases 1. Nearly 30% of all drugs approved by the US Food and Drug ...

Radius Announces Topline Results of Successful Phase 1b Clinical Trial of BA058 Microneedle Patch for the Transdermal Treatment of Osteoporosis Technical Feasibility Demonstrated for Transdermal ...

ANAHEIM, CA--(Marketwired - Jan 19, 2016) - The transdermal and subcutaneous drug delivery market is growing dramatically due to the fact that these drug delivery systems are more convenient for ...

3M Drug Delivery Systems has successfully designed a proof of concept device using a solid microstructured transdermal system for the systemic delivery of high-potency pharmaceuticals. The technology ...

What is transdermal norelgestromin/ethinyl estradiol used for? Transdermal norelgestromin/ethinyl estradiol is a combination birth control patch (contraceptive) used to prevent pregnancy in women who ...

CAMBRIDGE, MA--(Marketwire - Sep 27, 2012) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's ...

CAMBRIDGE, MA -- Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, today ...